Snowball logo
logo
ADAP_logo

Adaptimmune Therapeutics Plc

$0.055$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202021202220232024TTM
Revenue
Total revenue
3.9586.14927.1560.2817865.08
COGS
91.57111.1127.79.8570590.079.134841
Gross Profit
(87.61)(104.9)(100.6)50.4217861.7
Operating Expenses & Income
Operating Income
(133.4)(162.2)(164)(138)(68.76)(164.2)
Total Operating Expenses
137.4168.4191.1188.4246.7225.9
R&D Expenses
91.57111.1127.7126.5149.1125.2
Selling General & Admin Expenses
45.857.363.3971.8180.8181.16
Earnings from Continuing Operations
Interest Expense
(3.475)(4.947)(1.006)-(3.348)(5.665)
Interest Income
2.3131.0951.5425.9646.5965.018
Income Tax Expense
0.1620.7912.4971.3363.5760.735008
Net Income
Net Income
(130.1)(158.1)(165.5)(113.9)(70.81)(169.8)
Supplemental
EBIT
(133.5)(162.2)(161.7)(138)(63.89)(160.4)
EBITDA
(125.8)(155.7)(155.6)(128.2)(52.66)(149.8)
In millions of USD, except % and values per 1 share